Epinephrine Injector

Open Solicitation Posted

Solicitation number
SPE2D2-26-R-0009
Agency
Responses due
Set-aside
No set-aside

Opportunity facts

Notice details come from SAM.gov. Updated .

About this opportunity

The Defense Logistics Agency Troop Support Medical is soliciting a national requirements contract for Epinephrine 0.3 MG/0.3 ML Injection, Auto-Injector 2S in 2-count boxes, with proposals due November 16, 2026. This is an unrestricted, fully competitive acquisition with no set-aside using FAR Part 12 commercial item procedures.

The contract is firm-fixed-price with a one-year base period and four optional one-year extensions, for a maximum five-year term. Estimated annual demand across all agencies is 473,905 boxes: Department of Defense 114,780 boxes, Department of Veterans Affairs 336,610 boxes, Indian Health Service 22,515 boxes, and Bureau of Prisons. Customers purchase through the DLA and VA Pharmaceutical Prime Vendor programs.

Award will be made to the lowest-priced technically acceptable offeror. All quoted prices must be exclusive of federal excise tax and include a 0.5 percent cost recovery fee embedded in unit pricing for both the base year and all option years. Contract performance must commence within 45 days of award, with prices effective 15 days thereafter.

Offerors must submit FDA-approved products with current Good Manufacturing Practice compliance, a Letter of Certification if the manufacturer or Letter of Commitment if a distributor, completed representations and certifications, trade agreement compliance documentation showing country of origin, SF 1449, and past performance data covering three relevant contracts from the prior three years. Contractors must establish business-to-business agreements with each Pharmaceutical Prime Vendor contractor, register products with RXNorm, First Data Bank, and Medi-Span within five days of award, and comply with barcode labeling and Drug Supply Chain Security Act requirements. Large business offerors must submit a subcontracting plan with small business goals. Quarterly sales reporting is due within 60 days of each quarter end. The NAICS code is 325412 and PSC is 6505.

Notice text

The Defense Logistics Agency is issuing a solicitation for a national requirements contract for Epinephrine Injectors. Procurement details follow.
 

Epinephrine 0.3 MG/0.3 ML Injection, Auto-Injector 2S in 2 count bottles.

This will be an unrestricted and fully competitive acquisition. The contract will be a firm-fixed price, requirements type contract with a one-year base and four one-year options. A contract resulting from this solicitation will establish a national supply source, in accordance with FAR 52.216-21 (Requirements), to provide the items listed in the schedule for purchase by Department of Defense, Department of Veterans Affairs, Indian Health Service and Bureau of Prisons customers through the DLA and VA prime vendor programs. The annual usage estimates will be provided in the Schedule of Supplies section of the solicitation. This is a commercial item and will be solicited using FAR part 12. All sources may submit a proposal which shall be considered by the agency.  

A copy of the solicitation will be posted to the DLA Bid Board System (DIBBS) at https://www.dibbs.bsm.dla.mil and Sam.Gov at https://sam.gov. Interested parties should contact Jeremy Brown at (445) 737-5419, (jeremy.brown@dla.mil) for any questions/comments. Interested parties are further advised to set up automated notifications of pre-solicitation or solicitation changes through this website. The current solicitation date is October of 2026.    

Files

File Type Posted
Ephinephrine Injector Solicitation.pdf PDF
Amendment001.pdf PDF
Ephinephrine Injector Solicitation_updated9.30.26.docx DOCX document

Notice history

Notice Type Posted
This notice Latest solicitation Solicitation
Epinephrine Injector Original Pre-Solicitation

Similar open opportunities

Opportunity Agency Set-aside Responses due
Methylphenidate ER NAICS 325412 Medical Supply Chain No set-aside
6505--Sodium Bicarbonate Injection Vial Restricted to Made in America NAICS 325412 National Acquisition Center No set-aside
6505--Imatinib Tablets NAICS 325412 National Acquisition Center No set-aside

On GovTribe

Work this opportunity

  • Track it in your pipeline
  • Find teaming partners
  • Similar opportunities
  • Ask GovTribe AI about this opportunity